Skip to Main content Skip to Navigation
Journal articles

EMMPRIN-mediated MMP regulation in tumor and endothelial cells.

Abstract : Tumor invasion and metastasis are multistep processes which require extracellular matrix remodeling by proteolytic enzymes such as matrix metalloproteinases (MMPs). The production of these enzymes is stimulated by many soluble or cell-bound factors. Among these factors, extracellular matrix metalloproteinase inducer (EMMPRIN) is known to increase in vitro stromal cell production of MMP-1, MMP-2 and MMP-3. In this study, we demonstrated that EMMPRIN-transfected MDA-MB-436 tumor cells displayed a more invasive capacity than vector-transfected cells in a modified Boyden chamber invasion assay. Using gelatin zymography and protein analyses, we showed that EMMPRIN-transfected cancer cells produced significantly more latent and active MMP-2 and MMP-3 than vector-transfected cancer cells. We found that EMMPRIN did not regulate MMP-1, MMP-9, membrane type-1 MMP (MT1-MMP) expression and had also no effect on the production of the specific tissue inhibitors of MMPs (TIMPs), TIMP-1 and TIMP-2. We also demonstrated that tumor-derived EMMPRIN stimulated MMP-1, -2, and -3 without modification of MMP-9, MT1-MMP, TIMP-1 and TIMP-2 production in human umbilical vein endothelial cells (HUVEC). These data provide support for the role of EMMPRIN in tumor invasion, metastasis, and neoangiogenesis by stimulating extracellular matrix remodeling around tumor cell clusters, stroma, and blood vessels.
Complete list of metadata
Contributor : Philippe Birembaut <>
Submitted on : Thursday, May 31, 2007 - 11:07:36 AM
Last modification on : Friday, August 2, 2019 - 4:18:13 PM


  • HAL Id : inserm-00150649, version 1
  • PUBMED : 12553375



Stéphanie Caudroy, Myriam Polette, Béatrice Nawrocki-Raby, Jian Cao, Bryan Toole, et al.. EMMPRIN-mediated MMP regulation in tumor and endothelial cells.. Clinical and Experimental Metastasis, Springer Verlag, 2002, 19 (8), pp.697-702. ⟨inserm-00150649⟩



Record views